Key result
Tailoring P2Y12 inhibiting therapy is a key focus for managing elderly patients with myocardial infarction undergoing primary percutaneous coronary intervention.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May inform tailored P2Y12 selection in elderly MI patients post-PCI; hypothesis-generating and requires randomized confirmation.
See Article Schmucker et al.
No takes yet. Share an insight, caveat, or question.
Capranzano et al. (2019) studied this question. Tailoring P2Y12 inhibiting therapy is a key focus for managing elderly patients with myocardial infarction undergoing primary percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: